Umang Vohra, MD & Global CEO Cipla said: "The prevalence of cancer and rheumatoid arthritis is widely spread across India, and Cipla can contribute to provide broader access to innovative medicines like tocilizumab and bevacizumab."from India News | Latest News Headlines & Live Updates from India - Times of India http://ift.tt/2HQfbH2
